Harmony Biosciences Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4131971040
USD
38.25
2.24 (6.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
714.73
582.02
437.86
305.44
159.74
6.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
714.73
582.02
437.86
305.44
159.74
6.00
0.00
Raw Material Cost
180.66
145.08
106.45
73.94
27.74
4.79
0.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.50
23.76
18.80
24.19
28.22
6.07
0.00
Selling and Distribution Expenses
197.42
168.85
140.34
113.60
95.57
77.52
28.88
Other Expenses
12.83
5.23
5.21
0.62
-0.88
6.35
1.24
Total Expenditure (Excl Depreciation)
523.91
389.99
317.67
217.91
142.76
151.90
41.44
Operating Profit (PBDIT) excl Other Income
190.79999999999998
192
120.19999999999999
87.5
17
-145.9
-41.4
Other Income
18.47
14.89
3.29
0.24
-3.07
0.00
1.54
Operating Profit (PBDIT)
233.41
231.28
146.87
106.61
24.15
-142.69
-39.71
Interest
17.50
23.76
18.80
24.19
28.22
6.07
0.00
Exceptional Items
0.00
-9.77
0.00
-26.15
-22.64
0.00
0.00
Gross Profit (PBDT)
534.07
436.94
331.41
231.50
132.00
1.21
-0.18
Depreciation
24.11
24.36
23.39
18.84
10.24
3.21
0.18
Profit Before Tax
191.80
173.40
104.69
37.43
-36.94
-151.98
-39.90
Tax
46.31
44.54
-76.78
2.83
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
145.49
128.85
181.47
34.60
-36.94
-151.98
-39.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
145.49
128.85
181.47
34.60
-36.94
-151.98
-39.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
145.49
128.85
181.47
34.60
-36.94
-151.98
-39.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
659.15
466.99
402.84
186.51
97.18
-422.86
-242.67
Earnings per share (EPS)
2.51
2.13
2.97
0.58
-1.12
-2.94
-1.1
Diluted Earnings per share
2.51
2.13
2.97
0.58
-1.12
-2.94
-1.1
Operating Profit Margin (Excl OI)
26.7%
32.99%
27.45%
28.66%
10.63%
-2433.76%
0.0%
Gross Profit Margin
30.21%
33.98%
29.25%
18.42%
-16.72%
-2481.52%
0.0%
PAT Margin
20.36%
22.14%
41.44%
11.33%
-23.13%
-2535.06%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 22.80% vs 32.91% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 12.88% vs -28.98% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -0.69% vs 50.70% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -26.47% vs 26.60% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Harmony Biosciences Holdings, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
714.73
0.00
714.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
714.73
0.00
714.73
Raw Material Cost
180.66
2.56
178.10
6,957.03%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
119.06
-119.06
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
17.50
0.00
17.50
Selling and Distribution Expenses
197.42
68.90
128.52
186.53%
Other Expenses
12.83
8.88
3.95
44.48%
Total Expenditure (Excl Depreciation)
523.91
279.30
244.61
87.58%
Operating Profit (PBDIT) excl Other Income
190.83
-279.30
470.13
168.32%
Other Income
18.47
40.88
-22.41
-54.82%
Operating Profit (PBDIT)
233.41
-235.86
469.27
198.96%
Interest
17.50
0.00
17.50
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
534.07
-2.56
536.63
20,962.11%
Depreciation
24.11
2.56
21.55
841.80%
Profit Before Tax
191.80
-238.42
430.22
180.45%
Tax
46.31
-4.09
50.40
1,232.27%
Provisions and contingencies
0
0
0.00
Profit After Tax
145.49
-234.33
379.82
162.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
145.49
-234.33
379.82
162.09%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
145.49
-234.33
379.82
162.09%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
659.15
754.90
-95.75
-12.68%
Earnings per share (EPS)
2.51
-3.01
5.52
183.39%
Diluted Earnings per share
2.51
-3.01
5.52
183.39%
Operating Profit Margin (Excl OI)
26.70%
0.00%
0.00
26.70%
Gross Profit Margin
30.21%
0.00%
0.00
30.21%
PAT Margin
20.36%
0.00%
0.00
20.36%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 71.47 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 22.80% vs 32.91% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 14.55 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 12.88% vs -28.98% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.49 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -0.69% vs 50.70% in Dec 2023

Annual - Interest
Interest 1.75 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -26.47% vs 26.60% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.70%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023